Research suggests that intranasal nanosuspensions offer a promising way to formulate and deliver drugs that are poorly soluble in water to patients with chronic conditions.
This article reviews sources of excipient variability, including raw materials and processing, both of which may vary from supplier to supplier and from plant to plant for a single manufacturer.
With the evolution of scalability of peripheral blood protein glycosylation, research has expanded for new biomarkers.
Collaboration is a key component to achieving long-term success with genetic medicines.
The Start-Up Market at CPHI Barcelona will bring together 27 start-ups, innovators, and small enterprises from across the pharma landscape.
Webinar Date/Time: Wed, Feb 7, 2024 10:30 AM CET (4:30 AM EST)
Webinar Date/Time: Wed, Jun 14, 2023 11:00 AM EDT
More work is needed to educate businesses on the value of innovation and the availability of funding.
How automated visual inspection monitors the packaging quality of vaccines
In this paper, the authors lay out some commonly accepted HCP analytical methods, the challenges of HCP assay, and provide recommendations on what can easily be accomplished in-house and when it may be better to outsource.
The advantages of using an automated powder dispensing system in a ventilated balance enclosure for efficient handling and effective containment of potent compounds are discussed.
Researchers demonstrated a new cell lysis method using a novel solution to improve viral vector production.
CROMA continuous coater brings an innovative technological progress in manufacturing based on modularity and truly continuous film coating of tables.
Harmonization of global regulations fosters innovation and ensures quality medicines.
This article presents the results of a survey conducted to gain insight on the impact of the COVID-19 pandemic on biomanufacturing operations.
Image analysis is crucial for particle analysis of complex finished drug products.
Despite its understandable hesitancy, the pharma industry is facing a need for more widespread adoption of cloud-based solutions.
The authors describe the Piers' catalysts and detail latest progress in olefin-metathesis catalyst technology.
A recent innovation in infrared spectroscopy, Microfluidic Modulation Spectroscopy has been shown to improve characterization of secondary protein structure.
Key information is needed for excipients and their potential impact on continuous manufacturing processes.
The biggest differences between the development of a biosimilar and a generic medicine lie primarily in the preclinical and clinical stages.
Particle performance in a DPI can be optimized by fine-tuning the formulation and manufacturing process parameters.
Having intelligent analytical tools can advance the detection of unknown impurities, which is important for ensuring small-molecule ingredient purity.
Advancing the use of AI to understand the whole of a disease can reveal drug development insights that lead to drug discovery breakthroughs.
This article provides an overview of solutions to address key challenges facing vaccine developers or CDMOs wishing to build their own commercial-scale mRNA production facilities.
This article presents the results of a survey conducted to gain insight on the impact of the COVID-19 pandemic on biomanufacturing operations.
Utilizing integrated active radio frequency identification (RFID) and real-time asset management systems can yield commercial and compliance benefits.